Conclusion: This study confirms a strong association between BBS1 mutations and obesity in BBS patients, with homozygous and compound heterozygous mutations contributing to more severe clinical manifestations. The gene discussed is BBS1; the disease is obesity due to melanocortin 4 receptor deficiency.